Assessment of the Safety, Tolerability and Pharmacodynamics After Administration of One Dose of AZD8601 to Male Patients With Type II Diabetes Mellitus (T2DM)
Clinical trial NCT02935712 · COMPLETED
Trial details
- NCT number
- NCT02935712
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-16
- Primary completion
- 2017-08-04
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.